Jfl Life Sciences share news, announcements and annual reports
NSE: JFLLIFEPharmaceuticals & Biotechnology
Share price at the NSE close on 28 Oct 2026. Previous close ₹10.25.
28 Oct: open ₹10.00, high ₹10.00, low ₹10.00
- Next results date: the board meets on 2 Nov 2026 to consider: financial results. The notice · Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. Market capitalisation: how it is worked out
- ₹33 Cr
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 4.87
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 0.72
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 15.9%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 15.9%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.47
- Volume, NSEVolume. Shares traded on the last trading day. Volume in the glossary
- 6,000
Jfl Life Sciences has 159 announcements on record, routine notices left out; 1 in the 30 days to 28 Oct 2026, the latest on 22 Oct 2026.
Next board meeting and results date
As the company gave notice to the exchange.Jfl Life Sciences quarterly results
The board meets on 2 Nov 2026 to consider financial results
Notice filed 22 Oct 2026
To consider and approve the financial results for the period ended September 30, 2026
Jfl Life Sciences annual reports, presentations and earnings calls
The company's own documents, latest first.Jfl Life Sciences financials, year by year
Annual reports4
- Annual report, year to Mar 202631 Jul 2026
- Annual report, year to Mar 20252 Sep 2025
- Annual report, year to Mar 20243 Sep 2024
- Annual report, year to Mar 20234 Sep 2023, a zip file
Jfl Life Sciences share news and announcements
Newest first. Page 1 of 4.
Oct 2026
22 Oct · Board meeting
Aug 2026
26 Aug
25 Aug · Meeting
10 Aug · Results
Jul 2026
31 Jul · Meeting
Jun 2026
May 2026
29 May · Management
29 May · Results
Mar 2026
4 Mar · Corporate action
Feb 2026
Jan 2026
29 Jan · Results
Dec 2025
18 Dec · General Updates
Nov 2025
11 Nov · Results
Oct 2025
29 Oct · Amendment to AOA/MOA
25 Oct · General Updates
1 Oct · Board meeting
Sep 2025
27 Sep · General Updates
27 Sep · General Updates
26 Sep · Meeting
13 Sep · General Updates
3 Sep · General Updates
1 Sep · Board meeting
Aug 2025
23 Aug · Board meeting
18 Aug · Updates
11 Aug · Results
Jul 2025
1 Jul · General Updates
Jun 2025
28 Jun · Results
9 Jun · General Updates
9 Jun
May 2025
19 May · Board meeting
How the price met the news
The first session after each announcement, beside the market.
That dayThe first session's move. The first session's close after the announcement against the close before it, as a per cent change, on prices adjusted for splits and bonuses.Against the Nifty 500Against the Nifty 500. The share's move less the Nifty 500's move the same session, in percentage points (pts).Market median on that newsThe market's median move on that news. The middle first-session move of every listed company that filed the same kind of announcement, half moving more and half less.Five sessionsFive sessions' move. The close five sessions after the announcement against the close before it, as a per cent change.Five sessions against the Nifty 500Five sessions against the Nifty 500. The share's five-session move less the Nifty 500's move over the same five sessions, in percentage points (pts).Volume, times usualVolume, times usual. The session's shares traded divided by the average of the twenty sessions before it.
- 11 Aug 2026Resultsdown 4.69%−4.4 pts vs Nifty 500market median −0.7% · five sessions −9.4% (−8.6 pts vs Nifty 500) · volume 0.2× usual · The announcement
- 1 Jun 2026Resultsup 5.00%+6.0 pts vs Nifty 500market median −0.7% · five sessions +11.1% (+12.0 pts vs Nifty 500) · volume 3.4× usual · The announcement
- 30 Jan 2026Resultsup 4.78%+5.0 pts vs Nifty 500market median −0.7% · five sessions +1.0% (−0.8 pts vs Nifty 500) · volume 1.1× usual · The announcement
- 12 Nov 2025Resultsdown 0.74%−2.1 pts vs Nifty 500market median −0.7% · five sessions −11.9% (−12.4 pts vs Nifty 500) · volume 0.7× usual · The announcement
- 12 Aug 2025Resultsdown 4.91%−5.5 pts vs Nifty 500market median −0.7% · five sessions −7.7% (−10.5 pts vs Nifty 500) · volume 2.4× usual · The announcement
- 28 Jul 2025Board or managers changedup 2.58%+4.5 pts vs Nifty 500market median 0.0% · five sessions −9.4% (−6.7 pts vs Nifty 500) · volume 0.7× usual · The announcement
- 29 Jan 2025Board or managers changeddown 5.02%−3.7 pts vs Nifty 500market median 0.0% · five sessions −22.0% (−22.8 pts vs Nifty 500) · volume 0.1× usual · The announcement
- 14 Nov 2024Resultsdown 0.85%−1.1 pts vs Nifty 500market median −0.7% · five sessions +20.2% (+18.8 pts vs Nifty 500) · volume 1.2× usual · The announcement
- 23 Sep 2024Dividendup 1.06%+0.3 pts vs Nifty 500market median 0.0% · five sessions +0.7% (−0.5 pts vs Nifty 500) · volume 1.5× usual · The announcement
- 2 Sep 2024Dividenddown 0.41%−0.5 pts vs Nifty 500market median 0.0% · five sessions −3.2% (−2.2 pts vs Nifty 500) · volume 0.4× usual · The announcement
3 earlier announcements
- 2 Aug 2024Dividendup 3.99%+5.0 pts vs Nifty 500market median 0.0% · five sessions −10.9% (−8.4 pts vs Nifty 500) · volume 1.5× usual · The announcement
- 19 May 2023Board or managers changeddown 0.12%+0.4 pts vs Nifty 500market median 0.0% · five sessions +5.8% (+5.4 pts vs Nifty 500) · volume 0.7× usual · The announcement
- 7 Nov 2022Board or managers changedup 1.53%+1.0 pts vs Nifty 500market median 0.0% · five sessions −0.9% (−1.7 pts vs Nifty 500) · volume 0.7× usual · The announcement
Jfl Life Sciences results filing dates and deadlines
Listed companies must file quarterly results within 45 days, and the year's within 60.
Days to fileDays to file. The days from the period's end to the day the results reached the exchange.DeadlineDeadline, days. The days the rules allow from the period's end: 45 for a quarter or half year, and 60 for the year and the March quarter filed with it. A company that listed after the period ended has until 21 days after its listing where that is later.